BVEFX
Price
$21.29
Change
-$0.09 (-0.42%)
Updated
Aug 7 closing price
Net Assets
96.15M
VIVIX
Price
$68.98
Change
-$0.07 (-0.10%)
Updated
Aug 7 closing price
Net Assets
195.81B
Interact to see
Advertisement

BVEFX vs VIVIX

Header iconBVEFX vs VIVIX Comparison
Open Charts BVEFX vs VIVIXBanner chart's image
Becker Value Equity Retail
Price$21.29
Change-$0.09 (-0.42%)
VolumeN/A
Net Assets96.15M
Vanguard Value Index I
Price$68.98
Change-$0.07 (-0.10%)
VolumeN/A
Net Assets195.81B
BVEFX vs VIVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BVEFX vs. VIVIX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BVEFX is a Hold and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 196B vs. BVEFX (96.2M). VIVIX pays higher dividends than BVEFX: VIVIX (2.19) vs BVEFX (1.14). BVEFX was incepted earlier than VIVIX: BVEFX (22 years) vs VIVIX (27 years). BVEFX (1.04) is less costly to investors than VIVIX (0.04). BVEFX is a more actively managed with annual turnover of: 20.00 vs. VIVIX (9.00). BVEFX has a lower initial minimum investment than VIVIX: BVEFX (2500) vs VIVIX (5000000). VIVIX (10.53) and BVEFX (10.26) have marching annual gain over last year. VIVIX return over 5 years is better than : 67.40 vs. BVEFX (34.22).
BVEFXVIVIXBVEFX / VIVIX
Total Expense Ratio0.780.041,950%
Annual Report Gross Expense Ratio1.040.042,600%
Fund Existence22 years27 years-
Gain YTD7.7624.624168%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets96.2M196B0%
Annual Yield % from dividends1.142.1952%
Returns for 1 year10.2610.5397%
Returns for 3 years10.5428.8537%
Returns for 5 years34.2267.4051%
Returns for 10 years29.70109.9327%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGCIX132.53N/A
N/A
Gabelli Growth I
GMVRX16.16N/A
N/A
Goldman Sachs Small/Mid Cap Equity R
SSAQX78.33N/A
N/A
State Street US Core Equity Fund
MSVMX5.21N/A
N/A
Morgan Stanley Vitality Portfolio C
MNHWX26.68N/A
N/A
Manning & Napier Pro-Blend Max Term W